Breaking News, Promotions & Moves

Cytovance Names New CEO

Dr. Yan Wang has been with the company for three years, and has over two decades of industry experience

Cytovance Biologics has named Yan Wang, Ph.D., as chief executive officer.


Dr. Wang has been with Cytovance as a member of the Board of Directors since 2015 and has more than 20 years of experience in the pharmaceutical industry.

Dr. Wang also serves as president of Scientific Protein Laboratories LLC (SPL), a sister company to Cytovance.  Prior to his current positions, Dr. Wang was vice president of Business Development and Research at SPL, responsible for business development, product development and M&A activities. 
 
“I am extremely excited to join Cytovance,” said Dr. Wang. “My mission is to work with the experienced leadership team and the entire staff to take Cytovance to the next level and to provide the best develop and manufacturing services to the biopharmaceutical industry.”

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters